Chronic Hepatitis B – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034
Chronic Hepatitis B Market Outlook Thelansis’s “Chronic Hepatitis B Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Chronic Hepatitis B treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). Chronic Hepatitis B Overview Chronic Hepatitis B (CHB) infection is characterized by the presence of Hepatitis B surface antigen (HBsAg) in the serum for at least six months. Whereas HBsAg indicates the presence of hepatitis B viral infection, the markers HBeAg and HBV DNA, as determined by polymerase chain reaction (PCR) assays, are indicators of viral replication and infectivity. Severe complications associated with chronic infection en...